Milton Boyer

Milton Boyer is the Chief Executive Officer of Meridian Medical Technologies. Milton has over 25 years of experience in pharmaceutical contract development and manufacturing organizations, with a specific focus in sterile drug product. Previously, Milton served as Chief Executive Officer of SCA Pharmaceuticals, Senior Vice President of Drug Product Manufacturing at Albany Molecular Research (now Curia) and as Chief Executive Officer of OsoBio, a prior Altaris operating company. He holds degrees in Chemistry and Biochemistry from Texas Tech University.